Recursion Pharmaceuticals
publicBiotech & healthcare 0.9
In cascades:
- ← category beneficiary biotechStructure-prediction progress compounds AI-first drug-discovery platforms.
Score
Not scored today (fewer than 2 signal families).
Memos (0)
No memo yet — run pnpm memo 4137.
XBRL fundamentals (quarterly)
Revenue (Q)
latest $6.5M · 19q
Capex (Q)
latest $258k · 7q
R&D (Q)
latest $87.9M · 19q
Op. cash flow (Q)
latest $-81.1M · 7q